Search Tag: Masimo
Masimo announces FDA clearance of the rainbow acoustic monitoring® RAS-45 sensor
2018 10 Sep
Masimo announced today FDA clearance of RAS-45, an acoustic respiration sensor for rainbow Acoustic Monitoring® (RAM®), for infant and neonatal patients. RAM could previously be used to monitor adult and pediatric patients greater than 10 kg using RAS-125c and RAS-45 sensors. With clearance of the RAS-45 sensor for infant and neonatal patients, acoustic... Read more
New Study Investigates The Utility Of Masimo PVi® In Patients Undergoing Colorectal Surgery
2018 18 Jul
Masimo Radical-7® with PVi®, SpHb®, and RD rainbow SET™ Masimo (NASDAQ: MASI) has announced the findings of a recently published study in which researchers at Kocaeli University in Turkey compared the performance of conventional fluid management (CFM) to goal-directed fluid management (GDFM) using Masimo PVi® (pleth variability index, measured... Read more
Masimo Announces Vital Signs Check Application For The Root® Patient Monitoring Platform
2018 09 Jul
Masimo (NASDAQ: MASI) has announced the worldwide release of the Vital Signs Check Application, an integrated patient data collection and workflow application for the Masimo Root® patient monitoring and connectivity platform. Vital Signs Check, available for new and existing Root customers through a software upgrade, augments Root’s versatility by... Read more
Masimo And PositiveID Announce The U.S. Release Of TIR-1™
2018 20 Jun
Masimo and Thermomedics, a PositiveID company, has announced the debut and U.S. market release of TIR-1™, a non-contact Bluetooth®-enabled thermometer that integrates seamlessly with the Masimo Root® patient monitoring and connectivity platform. TIR-1 is an easy-to-use, clinical-grade infrared thermometer that provides forehead temperature measurements... Read more
Study Investigates the Utility of Continuous Noninvasive Hemoglobin Measurement With Masimo SpHb®
2018 05 Jun
Masimo has announced the findings of an abstract presented at Euroanaesthesia 2018 in which researchers compared Masimo noninvasive and continuous hemoglobin (SpHb®) to intermittent and invasive lab hemoglobin (LabHb) in reflecting iatrogenic hemodilution during incremental fluid administration of patients undergoing major surgery. 1... Read more
Masimo SET® Pulse Oximetry Helps Form Basis Of Utah Senate Resolution
2018 08 May
The Utah State Legislature and Governor Gary Herbert have recently signed into law the Concurrent Resolution on Deaths From Opioid-Induced Postoperative Respiratory Depression (SCR4). The resolution urges hospitals, clinicians, and researchers to examine and identify possible links between opioids and respiratory depression following surgery and encourages... Read more
Masimo O3® Regional Oximetry and SedLine® Brain Function Monitoring Power Two Investigations
2018 03 May
Masimo (NASDAQ: MASI) has announced the use of Masimo technologies – O3® regional oximetry and SedLine® brain function monitoring – in two abstracts presented at the 2018 Annual Meeting of the International Anesthesia Research Society(IARS). Both studies investigated links between postoperative delirium and particular biomarkers. In the first... Read more
Study Investigates the Utility of Masimo SpHb® in Post-operative Red RBC Transfusion Best Practices
2018 23 Apr
Masimo announced today the findings of an abstract presented at the 2018 Annual Meeting of the Network for the Advancement of Patient Blood Management, Haemostatis and Thrombosis (NATA), in which researchers investigated the utility of Masimo noninvasive and continuous hemoglobin (SpHb®) in supporting and enhancing red blood cell (RBC) transfusion... Read more
Masimo Announces UniView™
2018 02 Apr
Masimo announced today the release of UniView™, an integrated display of real-time data and alarms from multiple Masimo and third-party devices, designed to reduce clinician cognitive overload and improve patient safety. UniView promotes data sharing and team coordination among multiple clinicians. In operating rooms (ORs), in intensive care units... Read more
New Study Investigates the Performance of Masimo SpHb®
2018 12 Mar
Masimo announced today the findings of a recently published study in which researchers at Cairo University in Egypt evaluated the accuracy and trending of Masimo noninvasive and continuous hemoglobin (SpHb®), referenced to an invasive laboratory hemoglobin (Lab-Hb) measurement, during acute bleeding and after fluid resuscitation. In the study,... Read more